Availability of HIV and HCV On-Site Testing and Treatment at Syringe Service Programs in the United States
- 1 October 2018
- journal article
- letter
- Published by Ovid Technologies (Wolters Kluwer Health) in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 79 (2), e76-e78
- https://doi.org/10.1097/qai.0000000000001792
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Perceived discrimination among racial and ethnic minority drug users and the association with health care utilizationJournal of Ethnicity in Substance Abuse, 2017
- Vital Signs: Trends in HIV Diagnoses, Risk Behaviors, and Prevention Among Persons Who Inject Drugs — United StatesMorbidity and Mortality Weekly Report (MMWR), 2016
- Rising Mortality Associated With Hepatitis C Virus in the United States, 2003–2013Clinical Infectious Diseases, 2016
- Consistent Estimates of Very Low HIV Incidence Among People Who Inject Drugs: New York City, 2005–2014American Journal of Public Health, 2016
- Syringe Service Programs for Persons Who Inject Drugs in Urban, Suburban, and Rural Areas — United States, 2013Mmwr. Morbidity and Mortality Weekly Report, 2015
- Community Outbreak of HIV Infection Linked to Injection Drug Use of Oxymorphone--Indiana, 2015.2015
- HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.2014
- Stigma, discrimination and the health of illicit drug usersDrug and Alcohol Dependence, 2007
- Unmet need for recommended preventive health services among clients of California syringe exchange programs: Implications for quality improvementDrug and Alcohol Dependence, 2006
- An institutional analysis of HIV prevention efforts by the nation's outpatient drug abuse treatment units.Journal of Health and Social Behavior, 1999